Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: J Genet Couns. 2019 Sep 3;28(6):1107–1118. doi: 10.1002/jgc4.1161

Figure 1. Identification patients in the UDN undergoing whole exome sequencing (WES) previously facing insurance coverage barriers to WES.

Figure 1.

Sixty-six of 165 (40%) patients undergoing WES had no documented insurance coverage for WES prior to the UDN evaluation. WGS – whole genome sequencing; WES – whole exome sequencing; UDN – Undiagnosed Diseases Network